 <h1>Toremifene Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of toremifene include:</b> hot flash, nausea, vaginal discharge, and diaphoresis. <b>Other side effects include:</b> dizziness, edema, and vomiting.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to toremifene: oral tablet</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet)</p><p>Toremifene prolongs the QTc interval in a dose- and concentration-related manner and may cause a type of ventricular tachycardia called Torsade de pointes. This could result in syncope, seizures, and/or death. Toremifene should not be prescribed to patients with congenital/acquired QT prolongation, uncorrected hypokalemia, or uncorrected hypomagnesemia. Drugs known to prolong the QT interval and strong CYP3A4 inhibitors should be avoided.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, toremifene may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking toremifene:</p><p>
<i>Less common</i>
</p><ul>
<li>Anxiety</li>
<li>arm, back, or jaw pain</li>
<li>blurred vision</li>
<li>change in how much and how often you urinate</li>
<li>change in vaginal discharge</li>
<li>changes in skin color</li>
<li>changes in vision</li>
<li>changes in weight</li>
<li>chest pain, discomfort, tightness, or heaviness</li>
<li>confusion</li>
<li>constipation</li>
<li>cough</li>
<li>depression</li>
<li>dilated neck veins</li>
<li>dizziness, lightheadedness</li>
<li>dry mouth</li>
<li>fainting</li>
<li>fast, slow, or irregular heartbeat</li>
<li>inability to speak, incoherent speech</li>
<li>irregular breathing</li>
<li>loss of appetite</li>
<li>metallic taste in the tongue</li>
<li>muscle weakness</li>
<li>nausea</li>
<li>pain or discomfort in the arms, jaw, back, or neck</li>
<li>pain or feeling of pressure in the pelvis</li>
<li>pain, tenderness, or swelling of the foot or leg</li>
<li>seizures</li>
<li>severe or sudden headache</li>
<li>stomach pain</li>
<li>sweating</li>
<li>swelling of the face, fingers, feet, or lower legs</li>
<li>temporary blindness</li>
<li>tenderness, pain, swelling, warmth, skin discoloration, prominent superficial veins over the affected area</li>
<li>thirst</li>
<li>troubled breathing</li>
<li>unusual tiredness or weakness</li>
<li>vaginal bleeding</li>
<li>vomiting</li>
<li>weakness in the arm and or leg on one side of the body, sudden and severe</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Black, tarry stools</li>
<li>bleeding gums</li>
<li>blood in the urine or stools</li>
<li>chills</li>
<li>clay-colored stools</li>
<li>dark urine</li>
<li>fever</li>
<li>itching</li>
<li>painful or difficult urination</li>
<li>pinpoint red spots on the skin</li>
<li>rash</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>swollen glands</li>
<li>unpleasant breath odor</li>
<li>unusual bleeding or bruising</li>
<li>vomiting of blood</li>
<li>yellow eyes or skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of toremifene may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Blindness</li>
<li>decreased vision</li>
<li>dry eyes</li>
<li>feeling of warmth</li>
<li>redness of the face, neck, arms, and occasionally, the upper chest</li>
<li>sudden sweating</li>
<li>sweating</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Bone pain</li>
<li>changes in vision</li>
<li>double vision</li>
<li>eye pain</li>
<li>tearing</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Blistering, crusting, irritation, itching, or reddening of the skin</li>
<li>cracked, dry, or scaly skin</li>
<li>depression</li>
<li>difficulty having a bowel movement</li>
<li>feeling of constant movement of self or surroundings</li>
<li>feeling unusually cold</li>
<li>hair loss</li>
<li>lack or loss of strength</li>
<li>partial or slight paralysis</li>
<li>sensation of spinning</li>
<li>shakiness in the legs, arms, hands, or feet</li>
<li>thinning of the hair</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to toremifene: oral tablet</i></p><h3>General</h3><p>Adverse drug reactions are primarily due to the anti-estrogenic actions of this drug and typically occur at the beginning of treatment.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hot flashes/flushes (35%)</p>
<p><b>Common</b> (1% to 10%): Myocardial infarction, arrhythmia, cardiac failure, thrombophlebitis, thrombosis</p>
<p><b>Uncommon</b> (0.1% to 1%): Angina pectoris</p>
<p><b>Frequency not reported</b>: QT/QTc interval prolongation<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Sweating (20%)</p>
<p><b>Common</b> (1% to 10%): Rash, pruritus/itching</p>
<p><b>Uncommon</b> (0.1% to 1%): Skin discoloration</p>
<p><b>Rare</b> (less than 0.1%): Dermatitis, alopecia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Elevated AST (19%), elevated alkaline phosphatase (19%)</p>
<p><b>Common</b> (1% to 10%): Elevated bilirubin </p>
<p><b>Rare</b> (less than 0.1%): Jaundice</p>
<p><b>Very rare</b> (less than 0.01%): Hepatitis<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (14%)</p>
<p><b>Common</b> (1% to 10%): Vomiting</p>
<p><b>Uncommon</b> (0.1% to 1%): Constipation<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Vaginal discharge/leukorrhea (13%)</p>
<p><b>Common</b> (1% to 10%): Vaginal/uterine bleeding</p>
<p><b>Uncommon</b> (0.1% to 1%): Endometrial hypertrophy</p>
<p><b>Rare</b> (less than 0.1%): Endometrial polyps</p>
<p><b>Very rare</b> (less than 0.01%): Endometrial hyperplasia<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very common</b> (10% or more): Cataracts (10%)</p>
<p><b>Common</b> (1% to 10%): Dry eyes, abnormal visual fields, corneal keratopathy, glaucoma, abnormal vision/diplopia</p>
<p><b>Uncommon</b> (0.1% to 1%): Reversible corneal opacity (corneal verticillata/verticulata)<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Hypercalcemia</p>
<p><b>Uncommon</b> (0.1% to 1%): Anorexia, increased weight, appetite loss<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness, cerebrovascular accident/transient ischemic attack</p>
<p><b>Uncommon</b> (0.1% to 1%): Paresis, tremor, vertigo, headache</p>
<p><b>Rare</b> (less than 0.1%): Stiffness</p>
<p><b>Frequency not reported</b>: Rigors<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Edema, pain, fatigue</p>
<p><b>Uncommon</b> (0.1% to 1%): Asthenia, chest pain<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Depression</p>
<p><b>Uncommon</b> (0.1% to 1%): Insomnia</p>
<p><b>Rare</b> (less than 0.1%): Emotional lability<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Pulmonary embolism </p>
<p><b>Uncommon</b> (0.1% to 1%): Dyspnea<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Uncommon</b> (0.1% to 1%): Back pain<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Rare</b> (less than 0.1%): Leukopenia, thrombocytopenia</p>
<p><b>Frequency not reported</b>: Anemia<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Very rare</b> (less than 0.01%): Endometrial cancer</p>
<p><b>Frequency not reported</b>: Tumor flare<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Fareston (toremifene)." Schering Laboratories, Kenilworth, NJ. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about toremifene</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Imprints, Shape &amp; Color Data</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>1 Review</li>
<li>Drug class: hormones/antineoplastics</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Toremifene &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Fareston</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Breast Cancer</li>
<li>Breast Cancer, Metastatic</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to toremifene: oral tablet</i></p><h3>General</h3><p>Adverse drug reactions are primarily due to the anti-estrogenic actions of this drug and typically occur at the beginning of treatment.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hot flashes/flushes (35%)</p><p><b>Common</b> (1% to 10%): Myocardial infarction, arrhythmia, cardiac failure, thrombophlebitis, thrombosis</p><p><b>Uncommon</b> (0.1% to 1%): Angina pectoris</p><p><b>Frequency not reported</b>: QT/QTc interval prolongation<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Sweating (20%)</p><p><b>Common</b> (1% to 10%): Rash, pruritus/itching</p><p><b>Uncommon</b> (0.1% to 1%): Skin discoloration</p><p><b>Rare</b> (less than 0.1%): Dermatitis, alopecia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Elevated AST (19%), elevated alkaline phosphatase (19%)</p><p><b>Common</b> (1% to 10%): Elevated bilirubin </p><p><b>Rare</b> (less than 0.1%): Jaundice</p><p><b>Very rare</b> (less than 0.01%): Hepatitis<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (14%)</p><p><b>Common</b> (1% to 10%): Vomiting</p><p><b>Uncommon</b> (0.1% to 1%): Constipation<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Vaginal discharge/leukorrhea (13%)</p><p><b>Common</b> (1% to 10%): Vaginal/uterine bleeding</p><p><b>Uncommon</b> (0.1% to 1%): Endometrial hypertrophy</p><p><b>Rare</b> (less than 0.1%): Endometrial polyps</p><p><b>Very rare</b> (less than 0.01%): Endometrial hyperplasia<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very common</b> (10% or more): Cataracts (10%)</p><p><b>Common</b> (1% to 10%): Dry eyes, abnormal visual fields, corneal keratopathy, glaucoma, abnormal vision/diplopia</p><p><b>Uncommon</b> (0.1% to 1%): Reversible corneal opacity (corneal verticillata/verticulata)<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Hypercalcemia</p><p><b>Uncommon</b> (0.1% to 1%): Anorexia, increased weight, appetite loss<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness, cerebrovascular accident/transient ischemic attack</p><p><b>Uncommon</b> (0.1% to 1%): Paresis, tremor, vertigo, headache</p><p><b>Rare</b> (less than 0.1%): Stiffness</p><p><b>Frequency not reported</b>: Rigors<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Edema, pain, fatigue</p><p><b>Uncommon</b> (0.1% to 1%): Asthenia, chest pain<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Depression</p><p><b>Uncommon</b> (0.1% to 1%): Insomnia</p><p><b>Rare</b> (less than 0.1%): Emotional lability<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Pulmonary embolism </p><p><b>Uncommon</b> (0.1% to 1%): Dyspnea<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Uncommon</b> (0.1% to 1%): Back pain<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Rare</b> (less than 0.1%): Leukopenia, thrombocytopenia</p><p><b>Frequency not reported</b>: Anemia<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Very rare</b> (less than 0.01%): Endometrial cancer</p><p><b>Frequency not reported</b>: Tumor flare<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Fareston (toremifene)." Schering Laboratories, Kenilworth, NJ. </p><h2>More about toremifene</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Imprints, Shape &amp; Color Data</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>1 Review</li>
<li>Drug class: hormones/antineoplastics</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Toremifene &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Breast Cancer</li>
<li>Breast Cancer, Metastatic</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>